Carl Zeiss MicroImaging Inc., a leading provider of microscopy solutions for a variety of research, clinical and industrial applications, introduces its Laser TIRF 3 microscope system, designed to enable visualization of near-cell membrane dynamic processes while maintaining optimum specimen incubation conditions.

The Laser TIRF 3 also allows observation of single molecule dynamic processes in cell-free systems and, in combination with other techniques such as atomic force microscopy (AFM), the new microscope provides a complete solution for users in the life sciences, biochemistry, molecular biology and biophysics arenas.
The Laser TIRF 3 maintains Carl Zeiss' long-standing commitment to system flexibility. A range of incubation options maintain viable conditions for live cell experiments. Together with the 'definite focus' module, users can be assured of accurate quantitative data over long time periods. The new laser module may be equipped with up to four solid-state lasers, is AOTF-controlled (acousto-optical tuneable filter) and may be operated entirely from the AxioVision software interface.
The TIRF slider is available in two versions; either manual or fully-motorized and software controllable. The motorized version permits a given illumination angle to be set with significantly greater accuracy and speed than other current systems and the reproducible angle setting results in reproducible penetration depths for the light beam. Together with the corrected beam-path and special filter sets, the apochromatically-corrected optics of the TIRF slider guarantee maximum image quality.
AOTF control and angle setting are integrated into the 'fast image acquisition' module of the AxioVision software, enabling significantly more high resolution images to be acquired within any given timeframe.
The new Laser TIRF 3 builds on the attributes of the Laser TIRF, the first microscope to offer the combination of TIRF and transmitted-light contrasting techniques, such as DIC and brightfield, and enable the sequential recording of image pairs. By selectively exciting cellular fluorophores adsorbed, adhered, or bound to the surface and combining it with conventional epi-fluorescence, researchers can relate surface effects to internal cellular structures.

For more information: www.zeiss.com/micro


Related Content

News | Artificial Intelligence

July 17, 2025 — HOPPR, a secure AI development platform for medical imaging, has announced the commercial release of its ...

Time July 17, 2025
arrow
News | Breast Imaging

July 17, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time July 17, 2025
arrow
News | Focused Ultrasound Therapy

July 15, 2025 — Newswise —The UK Focused Ultrasound Foundation and Pancreatic Cancer UK have announced a new partnership ...

Time July 16, 2025
arrow
News | Digital Radiography (DR)

July 10, 2025 — Fujifilm Healthcare Americas Corp. has launched several advanced automated functions for its FDR ...

Time July 10, 2025
arrow
News | Computed Tomography (CT)

July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

June 26, 2025 — FUJIFILM VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging ...

Time June 27, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Radiology Business

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...

Time May 06, 2025
arrow
News | Radiology Imaging

Nov. 13, 2024 — Agfa Radiology Solutions will feature live demonstrations of state-of-the-art digital X-ray rooms ...

Time November 14, 2024
arrow
News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
Subscribe Now